In the last week, the Australian market has stayed flat, yet it is up 14% over the past year with earnings forecasted to grow by 12% annually. In this context of steady growth and positive earnings ...

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

One day can ruin years of success... The post Cochlear stock down 40%: How much has this cost ASX investors? appeared first on The Motley Fool Australia.

A bruising two-day stretch for the S&P/ASX 200 Health Care Index has underscored growing fragility in the sector, with ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

The average one-year price target for Cochlear Limited - Depositary Receipt (OTCPK:CHEOY) has been revised to $93.76 / share. This is a decrease of 14.65% from the prior estimate of $109.85 dated ...

Cochlear Limited has announced a daily update on its ongoing buy-back program, with 2,500 ordinary fully paid securities bought back on the previous day, adding to a total of 60,300 securities ...

Morgans analyst Derek Jellinek downgraded Cochlear Limited (CHEOF – Research Report) to a Hold today and set a price target of A$290.50. The company’s shares closed last Friday at $205.54. According ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

Goldman Sachs analyst Davinthra Thillainathan downgraded Cochlear Limited (CHEOF – Research Report) to a Hold on April 10 and set a price target of A$282.50. The company’s shares closed last Wednesday ...

Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The goal of this article is to teach you how to use price to earnings ratios (P/E ratios).

Thank you for standing by, and welcome to the Cochlear Limited H1 '23 Results Analyst and Media Briefing. There will be a presentation followed by a question-and-answer session. [Operator Instructions ...